BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 17630418)

  • 1. Comparisons of different measurements for monitoring diabetic cats treated with porcine insulin zinc suspension.
    Martin GJ; Rand JS
    Vet Rec; 2007 Jul; 161(2):52-8. PubMed ID: 17630418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of diabetes mellitus in cats with porcine insulin zinc suspension.
    Martin GJ; Rand JS
    Vet Rec; 2007 Jul; 161(3):88-94. PubMed ID: 17652434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of protamine zinc insulin for treatment of diabetes mellitus in cats.
    Nelson RW; Lynn RC; Wagner-Mann CC; Michels GM
    J Am Vet Med Assoc; 2001 Jan; 218(1):38-42. PubMed ID: 11149712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Field safety and efficacy of protamine zinc recombinant human insulin for treatment of diabetes mellitus in cats.
    Nelson RW; Henley K; Cole C;
    J Vet Intern Med; 2009; 23(4):787-93. PubMed ID: 19566845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of 46 cats with porcine lente insulin--a prospective, multicentre study.
    Michiels L; Reusch CE; Boari A; Petrie G; Mandigers P; Thollot IG; Rosenberg D; Mooney C; Bonfanti U; Font A; Sparkes A; Bewig K; Clercx C; Jensen AL; Horspool LJ
    J Feline Med Surg; 2008 Oct; 10(5):439-51. PubMed ID: 18619886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of serum fructosamine and blood glycosylated hemoglobin concentrations for assessment of glycemic control in cats with diabetes mellitus.
    Elliott DA; Nelson RW; Reusch CE; Feldman EC; Neal LA
    J Am Vet Med Assoc; 1999 Jun; 214(12):1794-8. PubMed ID: 10382020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of diet on glucose control in cats with diabetes mellitus treated with twice daily insulin glargine.
    Hall TD; Mahony O; Rozanski EA; Freeman LM
    J Feline Med Surg; 2009 Feb; 11(2):125-30. PubMed ID: 18835801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacology of a 40 IU/ml porcine lente insulin preparation in diabetic cats: findings during the first week and after 5 or 9 weeks of therapy.
    Martin GJ; Rand JS
    J Feline Med Surg; 2001 Mar; 3(1):23-30. PubMed ID: 11716627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Food intake and blood glucose in normal and diabetic cats fed ad libitum.
    Martin GJ; Rand JS
    J Feline Med Surg; 1999 Dec; 1(4):241-51. PubMed ID: 11714241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary study of protamine zinc recombinant insulin for the treatment of diabetes mellitus in cats.
    Norsworthy G; Lynn R; Cole C
    Vet Ther; 2009; 10(1-2):24-8. PubMed ID: 19742445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to insulin treatment and survival in 104 cats with diabetes mellitus (1985-1995).
    Goossens MM; Nelson RW; Feldman EC; Griffey SM
    J Vet Intern Med; 1998; 12(1):1-6. PubMed ID: 9503353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the sodium-glucose cotransporter 2 (SGLT2) inhibitor velagliflozin, a new drug with therapeutic potential to treat diabetes in cats.
    Hoenig M; Clark M; Schaeffer DJ; Reiche D
    J Vet Pharmacol Ther; 2018 Apr; 41(2):266-273. PubMed ID: 29139146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum fructosamine concentration as an index of glycemia in cats with diabetes mellitus and stress hyperglycemia.
    Crenshaw KL; Peterson ME; Heeb LA; Moroff SD; Nichols R
    J Vet Intern Med; 1996; 10(6):360-4. PubMed ID: 8947867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective evaluation of a protocol for transitioning porcine lente insulin-treated diabetic cats to human recombinant protamine zinc insulin.
    Gostelow R; Hazuchova K; Scudder C; Forcada Y; Church D; Niessen SJ
    J Feline Med Surg; 2018 Feb; 20(2):114-121. PubMed ID: 29172917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin therapy in cats with diabetes mellitus.
    Moise NS; Reimers TJ
    J Am Vet Med Assoc; 1983 Jan; 182(2):158-64. PubMed ID: 6298164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of glargine and lente insulins in cats with diabetes mellitus.
    Weaver KE; Rozanski EA; Mahony OM; Chan DL; Freeman LM
    J Vet Intern Med; 2006; 20(2):234-8. PubMed ID: 16594577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin detemir treatment in diabetic cats in a practice setting.
    Hoelmkjaer KM; Spodsberg EM; Bjornvad CR
    J Feline Med Surg; 2015 Feb; 17(2):144-51. PubMed ID: 24938314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of newly diagnosed diabetic cats with glargine insulin improves glycaemic control and results in higher probability of remission than protamine zinc and lente insulins.
    Marshall RD; Rand JS; Morton JM
    J Feline Med Surg; 2009 Aug; 11(8):683-91. PubMed ID: 19539509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of feline diabetes mellitus using an alpha-glucosidase inhibitor and a low-carbohydrate diet.
    Mazzaferro EM; Greco DS; Turner AS; Fettman MJ
    J Feline Med Surg; 2003 Jun; 5(3):183-9. PubMed ID: 12765629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pasireotide Long-Acting Release Treatment for Diabetic Cats with Underlying Hypersomatotropism.
    Gostelow R; Scudder C; Keyte S; Forcada Y; Fowkes RC; Schmid HA; Church DB; Niessen SJ
    J Vet Intern Med; 2017 Mar; 31(2):355-364. PubMed ID: 28145031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.